In a randomized clinical trial, researchers compared cognitive behavioral therapy or cognitive processing therapy against usual treatments for posttraumatic headache comorbid with PTSD.
Among adolescents, new-onset and worsened headaches during the COVID-19 pandemic were associated with significantly higher depression and general anxiety scores.
Patients with migraine have balance impairment, which is associated with fear of falls, dizziness disability, and kinesiophobia.
The resting-state functional connectivity of the amygdala and hippocampus can differentiate patients with migraine from healthy controls and patients with tension-type headache.
Individuals with headache before traumatic brain injury (TBI) are less likely to receive a diagnosis of posttraumatic headache.
Only one-third of individuals with neurologic symptoms following SARS-CoV-2 infection report complete symptom resolution by 6 months.
Atogepant appears to be effective and well tolerated for the preventive treatment of migraine.
Presenting at AHS 2022, researchers examined the effects of supplementation of B vitamins and a combination of these vitamins on women with episodic migraine.
Presenting at AHS 2022, researchers assessed the efficacy of a 1-year treatment period with ubrogepant 50 or 100 mg in patients with migraine attacks with mild and moderate or severe pain.
Headache disorders remain highly prevalent worldwide.
